Skip to content 
Adlai Nortye Ltd., a clinical-stage company, together with its subsidiaries, engages in the research and develops pharmaceutical products. Its product pipeline comprises AN0025, a small molecule EP4 antagonist which is in phase Ib and radiotherapy/chemoradiotherapy combination for the treatment of rectum cancer and esophageal cancer; and phase II trial for patients with moderate to high-risk rectal cancer. The company also develops AN9025, an oral small molecule pan-RAS(ON) inhibitor, which is in phase 1a clinical trials for the treatment of RAS-mutant cancers, including pancreatic, lung, and colorectal adenocarcinomas; AN4035, a proprietary CEACAM5-targeting antibody drug conjugate designed to deliver potent anti-tumor activity with an improved therapeutic window; and AN8025, a tri-specific antibody fusion protein which is in phase Ia clinical trial to treat advanced tumors. In addition, it develops AN4005, a small-molecule PD-L1 inhibitor that demonstrates antitumor activity by the blockade of PD-1/PD-L1 interaction which is in phase 1b clinical trial to activate cancer immunity. Further, the company is involved in technology transfer and consulting services business. Adlai Nortye Ltd. was founded in 2004 and is headquartered in North Brunswick Township, New Jersey. more
| Time Frame | ANL | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 5.96% | 1.72% | 1.69% |
| 1-Month Return | 65.89% | -0.67% | 9.85% |
| 3-Month Return | 49.15% | -7.87% | 4.73% |
| 6-Month Return | 863.23% | -0.44% | 7.96% |
| 1-Year Return | 637.28% | 8.17% | 29.54% |
| 3-Year Return | -0.47% | 9% | 75.46% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 45.73M | - | 5.00M | - | 5.00M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":10.93,"profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":10.93,"profit":true}] |
| Cost of Revenue | - | 2.04M | 2.22M | 1.87M | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":91.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":84.27,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Gross Profit | 45.73M | (2.04M) | 5.00M | (1.87M) | 5.00M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-4.46,"profit":false},{"date":"2023-12-31","value":10.93,"profit":true},{"date":"2024-12-31","value":-4.09,"profit":false},{"date":"2025-12-31","value":10.93,"profit":true}] |
| Gross Margin | 100.00% | - | 100.09% | - | 100.00% | [{"date":"2021-12-31","value":99.91,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":99.91,"profit":true}] |
| Operating Expenses | 54.37M | 67.27M | 72.55M | 52.93M | 40.70M | [{"date":"2021-12-31","value":74.94,"profit":true},{"date":"2022-12-31","value":92.72,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":72.95,"profit":true},{"date":"2025-12-31","value":56.1,"profit":true}] |
| Operating Income | (8.65M) | (67.27M) | (72.55M) | (52.93M) | (35.70M) | [{"date":"2021-12-31","value":-864600000,"profit":false},{"date":"2022-12-31","value":-6727000000,"profit":false},{"date":"2023-12-31","value":-7255100000,"profit":false},{"date":"2024-12-31","value":-5292800000,"profit":false},{"date":"2025-12-31","value":-3569800000,"profit":false}] |
| Total Non-Operating Income/Expense | (49.37M) | 8.05M | (37.41M) | (885.00K) | (1.36M) | [{"date":"2021-12-31","value":-613.51,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-464.84,"profit":false},{"date":"2024-12-31","value":-11,"profit":false},{"date":"2025-12-31","value":-16.91,"profit":false}] |
| Pre-Tax Income | (56.68M) | (58.79M) | (109.23M) | (51.87M) | (35.53M) | [{"date":"2021-12-31","value":-5667800000,"profit":false},{"date":"2022-12-31","value":-5879000000,"profit":false},{"date":"2023-12-31","value":-10922800000,"profit":false},{"date":"2024-12-31","value":-5186900000,"profit":false},{"date":"2025-12-31","value":-3552800000,"profit":false}] |
| Income Taxes | (46.19M) | 8.31M | 643.00K | - | - | [{"date":"2021-12-31","value":-555.68,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":7.74,"profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income After Taxes | (10.49M) | (67.10M) | (109.87M) | - | - | [{"date":"2021-12-31","value":-1049000000,"profit":false},{"date":"2022-12-31","value":-6710200000,"profit":false},{"date":"2023-12-31","value":-10987100000,"profit":false},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | (56.68M) | (58.79M) | (104.87M) | (51.87M) | (35.53M) | [{"date":"2021-12-31","value":-5667800000,"profit":false},{"date":"2022-12-31","value":-5879000000,"profit":false},{"date":"2023-12-31","value":-10487100000,"profit":false},{"date":"2024-12-31","value":-5186900000,"profit":false},{"date":"2025-12-31","value":-3552800000,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | (56.68M) | (58.79M) | (109.23M) | (51.87M) | (35.53M) | [{"date":"2021-12-31","value":-5667800000,"profit":false},{"date":"2022-12-31","value":-5879000000,"profit":false},{"date":"2023-12-31","value":-10922800000,"profit":false},{"date":"2024-12-31","value":-5186900000,"profit":false},{"date":"2025-12-31","value":-3552800000,"profit":false}] |
| EPS (Diluted) | - | - | (2.56) | - | (1.17) | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-256,"profit":false},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":-117,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
| ANL | |
|---|---|
| Cash Ratio | 0.57 |
| Current Ratio | 0.65 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| ANL | |
|---|---|
| ROA (LTM) | -42.22% |
| ROE (LTM) | -414.01% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| ANL | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 1.24 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.24 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| ANL | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 192.29 |
| P/B | 82.76 |
| Price/FCF | NM |
| EV/R | 193.77 |
| EV/Ebitda | NM |
Adlai Nortye Ltd. American Depositary Shares (ANL) share price today is $14.27
Yes, Indians can buy shares of Adlai Nortye Ltd. American Depositary Shares (ANL) on Vested. To buy
Yes, you can purchase fractional shares of Adlai Nortye Ltd. American Depositary Shares (ANL) via the Vested app. You can start investing in Adlai Nortye Ltd. American Depositary Shares (ANL) with a minimum investment of $1.
You can invest in shares of Adlai Nortye Ltd. American Depositary Shares (ANL) via Vested in three simple steps:
The 52-week high price of Adlai Nortye Ltd. American Depositary Shares (ANL) is $17.25. The 52-week low price of Adlai Nortye Ltd. American Depositary Shares (ANL) is $0.88.
The price-to-earnings (P/E) ratio of Adlai Nortye Ltd. American Depositary Shares (ANL) is
The price-to-book (P/B) ratio of Adlai Nortye Ltd. American Depositary Shares (ANL) is 82.76
The dividend yield of Adlai Nortye Ltd. American Depositary Shares (ANL) is 0.00%
The market capitalization of Adlai Nortye Ltd. American Depositary Shares (ANL) is $961.46M
The stock symbol (or ticker) of Adlai Nortye Ltd. American Depositary Shares is ANL
Consider the share price of Adlai Nortye Ltd. American Depositary Shares as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Adlai Nortye Ltd. American Depositary Shares has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Adlai Nortye Ltd. American Depositary Shares shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Adlai Nortye Ltd. American Depositary Shares stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Adlai Nortye Ltd. American Depositary Shares and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Adlai Nortye Ltd. American Depositary Shares stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
